Gerrit Meijer

Professor of Oncologic Pathology

University Medical Center Groningen

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Biostatistics

100%

Cell Biology

50%

Cancer Biology

100%

Colorectal Cancer

60%

Biomarker Research

50%

Oncology

50%

Genomic

50%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles26

Aberrant <scp><i>PRDM2</i></scp> methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers

Article Link

Year:

2024

CIBRA identifies genomic alterations with a system-wide impact on tumor biology

Article Link

Year:

2024

FECAL IMMUNOCHEMICAL TEST TO DETECT COLORECTAL NEOPLASIA IN LYNCH SYNDROME – A PROSPECTIVE MULTICENTER STUDY

Article Link

Year:

2024

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer

Article Link

Year:

2024

Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

Article Link

Year:

2024

Polyketide synthase positive Escherichia coli one‐time measurement in stool is not informative of colorectal cancer risk in a screening setting

Article Link

Year:

2024

Combining Colonoscopy With Fecal Immunochemical Test Can Improve Current Familial Colorectal Cancer Colonoscopy Surveillance: A Modelling Study.

Article Link

Year:

2024

Stool-Based Testing for Post-Polypectomy Colorectal Cancer Surveillance Safely Reduces Colonoscopies: The Molecular Stool Testing for Colorectal Cancer Surveillance Study.

Article Link

Year:

2024

The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study.

Article Link

Year:

2024

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.

Article Link

Year:

2023

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells.

Article Link

Year:

2023

A dysfunctional T cell gene signature for predicting non-response to PD-1 blockade in non-small cell lung cancer that is suitable for routine clinical diagnostics.

Article Link

Year:

2023

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

Article Link

Year:

2023

Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.

Article Link

Year:

2023

Post-colonoscopy colorectal cancers in a national FIT-based CRC screening program.

Article Link

Year:

2023

Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models.

Article Link

Year:

2023

Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.

Article Link

Year:

2023

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study.

Article Link

Year:

2023

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.

Article Link

Year:

2022

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.

Article Link

Year:

2022

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.

Article Link

Year:

2022

Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer

Article Link

Year:

2022

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

Article Link

Year:

2022

Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis.

Article Link

Year:

2022

Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas.

Article Link

Year:

2022

PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC.

Article Link

Year:

2022

Collaborators16

Robert JC Steele

Research Professor

UNITED KINGDOM

Sanne Abeln

University of Amsterdam

NETHERLANDS

Robert Bresalier

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Valesca Retèl

Erasmus University Rotterdam

NETHERLANDS

Michel M. van den Heuvel

Radboud University Medical Center

NETHERLANDS

Guangxu Jin

Assistant Professor (Tenure-Track)

Wake Forest University

UNITED STATES

Remond J.A. Fijneman

University Medical Center Groningen

NETHERLANDS

Graeme Young

Flinders University

AUSTRALIA

Evelien Dekker

Professor

Amsterdam University Medical Centers

NETHERLANDS

Roelof Koster

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

NETHERLANDS

Lydia GUITTET

Université de Caen Normandie

FRANCE

Egbert Smit

Leiden University Medical Center

NETHERLANDS

Ed Schuuring

University Medical Center Groningen

NETHERLANDS

Carel JM van Noesel

NETHERLANDS

Beatrice Lauby-Secretan

Head, IARC Handbooks Programme

International Agency for Research on Cancer

FRANCE

Soufyan Lakbir

University of Amsterdam

NETHERLANDS

How do I reach out?

Meet Kite AI